Source:http://linkedlifedata.com/resource/pubmed/id/16514319
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2006-3-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0269-9370
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
790-1
|
pubmed:meshHeading |
pubmed-meshheading:16514319-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16514319-Antiviral Agents,
pubmed-meshheading:16514319-Disease Progression,
pubmed-meshheading:16514319-HIV Infections,
pubmed-meshheading:16514319-HIV-1,
pubmed-meshheading:16514319-Hepatitis B,
pubmed-meshheading:16514319-Hepatitis B virus,
pubmed-meshheading:16514319-Humans
|
pubmed:year |
2006
|
pubmed:articleTitle |
Immune reconstitution: bad or good factor in hepatitis B virus and HIV co-infection?
|
pubmed:publicationType |
Letter,
Comment
|